Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis.
about
Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway.Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy.Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience.The Inverse Association between the Baseline Renal Function and Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Molecular-Targeted Agents.Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four cases.
P2860
Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@ast
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@en
type
label
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@ast
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@en
prefLabel
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@ast
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@en
P2093
P2860
P1476
Efficacy and safety of temsiro ...... ell carcinoma on hemodialysis.
@en
P2093
Hideaki Miyake
Ken-Ichi Harada
Masato Fujisawa
Yuji Kusuda
P2860
P2888
P304
P356
10.1007/S10147-012-0492-7
P577
2012-11-01T00:00:00Z